EcoDrugPlus

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSTNIG00000018493
Gene Symbol: NAMPT
3 Cross references
225 Possible Orthologues:

Notch Receptor 1b

Ensembl ID : ENSTNIG00000015591
Gene Symbol: NOTCH1B
2 Cross references
201 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSTNIG00000018559
Gene Symbol: NOTCH3
2 Cross references
197 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSTNIG00000002693
Gene Symbol: NFKB1
3 Cross references
200 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 3

Ensembl ID : ENSTNIG00000009590
Gene Symbol: NR1H3
2 Cross references
391 Possible Orthologues:

Nuclear Receptor Subfamily 1, Group H, Member 4

Ensembl ID : ENSTNIG00000012144
Gene Symbol: NR1H4
2 Cross references
387 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSTNIG00000018209
Gene Symbol: NR3C1
3 Cross references
205 Possible Orthologues:

Nuclear Receptor Subfamily 3, Group C, Member 1 (Glucocorticoid Receptor)

Ensembl ID : ENSTNIG00000008946
Gene Symbol: NR3C1
2 Cross references
205 Possible Orthologues:

Nuclear Receptor Subfamily 3, Group C, Member 2

Ensembl ID : ENSTNIG00000017732
Gene Symbol: NR3C2
2 Cross references
208 Possible Orthologues:

Opiate Receptor-Like 1

Ensembl ID : ENSTNIG00000011334
Gene Symbol: OPRL1
3 Cross references
189 Possible Orthologues:

Opioid Receptor Kappa 1

Ensembl ID : ENSTNIG00000017125
Gene Symbol: OPRK1
3 Cross references
197 Possible Orthologues:

Opioid Receptor, Delta 1b

Ensembl ID : ENSTNIG00000009663
Gene Symbol: OPRD1B
3 Cross references
179 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).